UCSF at AACR 2025

Image
UCSF at AACR25

Each year UCSF Helen Diller Family Comprehensive Cancer Center members, physicians, faculty members, and advocates participate in the Annual Meeting of the American Association for Cancer Research (AACR). 

Held April 25-30th in Chicago, the theme of this year’s conference, “Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact,” showcases the latest advances in the biology, prevention, detection, diagnosis, and treatment of cancer as well as state-of-the-art concepts and technologies shaping cancer research today. 

YouTube Playlist: Deeper Dive into AACR Presentations

Featured videos of presenters and attendees

  • Javid Moslehi, MD | Cardio-Oncology: A Novel Platform for Investigation
  • Xiaokun Shu, PhD | Experimental and Molecular Therapeutics, Drug Development
  • Frank McCormick, PhD, FRS, DSc | Developments in RAS Signaling Inhibition UCSF Cancer
  • Travis Zack, MD, PhD | AI and Natural Language Processing
  • Valerie Weaver, PhD | Tissue Mechanics and Physical Forces in Cancer
  • Laura Huppert, MD | Liquid Biopsy: Circulating Tumor Cells 

Highlights on Social Media

Just one more day until #AACR25! Symposia, Posters, Educational Sessions, and more. View highlights of our @ucsanfrancisco.bsky.social expertise coming to @theaacr.bsky.social annual meeting in Chicago. ow.ly/9lrg50VHiz0

[image or embed]

— UCSF Helen Diller Family Comprehensive Cancer Center (@ucsfcancer.bsky.social) April 24, 2025 at 2:47 PM

Featured Presentations

Saturday, APRIL 26th

METHODS WORKSHOPS
Session MW10 - Statistics Made Simple, Engaging, and Practical: A Primer for Non-Statisticians
April 26, 2025, 12:30 - 2:00 PM     Room S405 - McCormick Pl South (Level 4)
1:00 PM - 1:20 PM    Boosting the quality and impact of preclinical studies through the power of statistics
Mi-Ok Kim, PhD, MS, MA UCSF  

Session MW02 - Application of AI and Natural Language Processing to Advance Cancer Research and Treatment 
April 26, 2025, 1:00 PM - 1:20 PM     Room S100 BC (Grand Ballroom BC) - McCormick Place South (Level 1)
1:00 PM - 1:20 PM    - Utilization of language models for medical information retrieval
Travis Zack, MD, PhD UCSF

ED SESSION
Session ED44 - Theranostics: The Nuts and Bolts
April 26, 2025, 2:30 PM - 4:00 PM     Room S401 - McCormick PlSouth (Level 4)
3:05 PM - 3:30 PM    - Evolving role of translational and clinical theranostics
Robert Flavell, PhD UCSF

Sunday, APRIL 27th

OPENING PLENARY SESSION
Session PL02 - Opening Plenary: Unifying Cancer Science and Medicine—A Continuum of Innovation for Impact
April 27, 2025, 9:30 AM - 11:30 AM     Hall B1 - McCormick PlNorth (Level 3)
9:40 AM - 10:07 AM    - Overcoming the undruggable nature of the most common human oncogene, K-Ras
Kevan M. Shokat, PhD  UCSF

MAJOR SYMPOSIUM - Tumor Biology
SESSION SY42 - Tissue Mechanics and Physical Forces in Cancer
April 27, 2025, 1:00 - 2:30 PM     Room E450 A - McCormick Lakeside Center (Level 4)
1:30 PM - 1:50 PM    - Forcing cancer initiation and progression through myeloid lipid peroxidation-mediated DNA damage
Valerie M. Weaver, PhD. UCSF    

CLINICAL TRIALS PLENARY SESSION
SESSION CTPL01 - Advances in Immunotherapy
April 27, 2025, 1:00 PM - 3:00 PM     Arie Crown Theater - McCormick Lakeside (Level 2)
2:45 PM - 2:55 PM    - Discussant
Pamela N. Munster, MD. UCSF 

MINISYMPOSIUM – Clinical Research
MS.CL01.01 - Liquid Biopsy: Circulating Tumor Cells
April 27, 2025, 3:00 PM - 5:00 PM     Room E451 - McCormick Lakeside Center (Level 4)
3:50 PM - 4:05 PM    1147 - Development of a novel assay to detect circulating tumor cells in the cerebrospinal fluid of patients with leptomeningeal disease
Laura A. Huppert, MD  UCSF

CLINICAL TRIALS PLENARY SESSION
CTPL02 - New Frontiers in Precision Oncology
April 27, 2025, 3:30 PM - 5:30 PM     Arie Crown Theater - McCormick Lakeside (Level 2)
5:15 PM - 5:25 PM    - Discussant
Trever G. Bivona, MD, PhD  UCSF 

TOWN MEETING
Session TM07 - Charting the Trajectory for Advancements in Pediatric Cancer Research- A Pediatric Cancer Working Group Town Hall
April 27, 2025, 6:30 - 8:30 PM     Room S103 - McCormick PlSouth (Level 1)
7:00 PM - 7:10 PM    - Chair
Alejandro Sweet-Cordero, MD  UCSF 


Monday, APRIL 28th

MAJOR SYMPOSIUM     Molecular/Cellular Biology and Genetics
Session SY26 - Metabolism and Organelle Biology in Cancer
April 28, 2025, 10:15 AM - 11:45 AM     Location to be announced
10:15 AM - 10:16 AM    - Chairperson
Rushika M. Perera. UCSF 
11:20 AM - 11:35 AM    - Decoding novel lysosome functions in pancreatic cancer
Rushika M. Perera, PhD. UCSF 

MAJOR SYMPOSIUM     Chemistry, Drug Dev, Clinical Research
Session SY08 - Developments in RAS Signaling Inhibition: Bench to Bedside
April 28, 2025, 12:30 PM - 2:00 PM     Location to be announced
12:30 PM - 12:31 PM    - Chairperson & Presentation
12:35 PM - 12:55 PM    - The End of KRAS cancers?
Frank McCormick, PhD, FRS.  UCSF 

ADVANCES IN DIAGNOSTICS AND THERAPEUTICS
Session ADT04 - Challenges and Opportunities in the Development of Next Generation Antibody Drug Conjugates
April 28, 2025, 12:30 PM - 2:00 PM     Location to be announced
1:25 PM - 1:45 PM    - Managing and predicting toxicities from new and emerging ADCs
Hope S. Rugo. UCSF 

MAJOR SYMPOSIUM     Science and Health Policy, Regulatory Science and Policy
DC07 - Molecular Tumor Profiling for Pediatric Oncology
April 28, 2025, 3:00 PM - 4:30 PM     Room S106 - McCormick Place South (Level 1)
3:00 PM - 4:30 PM    - Chairperson
Alejandro Sweet-Cordero, MD UCSF


Tuesday, APRIL 29th

PLENARY    Tumor Microenvironment, Molecular/Cellular Bio
Session PL04 - Targeting the Cancer Ecosystem
April 29, 2025, 8:00 AM - 10:00 AM     Hall B1 - McCormick PlNorth (Level 3)
8:32 AM - 8:59 AM    - Leveraging tumor immune archetypes in treating cancer
Max Krummel, PhD. UCSF

CLINICAL TRIALS PLENARY SESSION
CTPL04 - Biologics and T-cell Engagers
April 29, 2025, 10:15 AM - 12:15 PM     Arie Crown Theater - McCormick Lakeside (Level 2)
11:00 AM - 11:10 AM    - Discussant
Hope S. Rugo. UCSF 

MAJOR SYMPOSIUM        Survivorship, Drug Dev, Clinical Research
Session SY05 - Cardio-Oncology: A Novel Platform for Investigation
April 29, 2025, 10:15 AM - 11:45 AM     Location to be announced
10:15 AM - 10:16 AM    - Chairperson & Presentation
10:20 AM - 10:40 AM    - Immune checkpoint inhibitors and cardiac toxicity: From mice to humans
Javid J. Moslehi, MD UCSF 

MAJOR SYMPOSIUM        Immunology
Session SY16 - Novel Classes of Human Cancer Rejection Antigens: Beyond Point Mutations
April 29, 2025, 10:15 AM - 11:45 AM     McCormick Lakeside Center (Level 3)
10:45 AM - 11:05 AM    - Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens
Hideho Okada, MD, PhD.  UCSF  

MINISYMPOSIUM - Novel Cancer Therapeutic Targets
April 29, 2025, 2:30 PM - 4:00 PM     Room S102 - McCormick Place South (Level 1)
2:50 PM - 3:05 PM    Unveiling the potent anti-tumor activity and underlying mechanism of action of the novel pan-RAF inhibitor exarafenib in BRAF-mutated NSCLC
Tadashi Manabe, MD, PhD.  UCSF

Wednesday, APRIL 30th

MAJOR SYMPOSIUM Experimental and Molecular Therapeutics,Drug Development
April 30, 2025, 10:15 AM - 11:45 AM     Location to be announced
Session SY29 - Biomolecular Condensates in Cancer: Mechanisms and Therapeutic Opportunities
10:45 AM - 11:05 AM    - New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation
Xiaokun Shu, PhD. UCSF 

PLENARY SESSION
Session PL06 - AACR Annual Meeting 2025 Highlights: Vision for the Future
April 30, 2025, 12:10 PM - 1:30 PM     Arie Crown Theater - McCormick Lakeside Center (Level 2)
12:39 PM - 1:04 PM    - Prevention, early detection, population sciences, and disparities research
Scarlett L. Gomez, PhD, MPH. UCSF